{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T08:34:05Z","timestamp":1774773245089,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002160","name":"Jain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Dysferlinopathies are a group of muscle disorders caused by mutations to dysferlin, a transmembrane protein involved in membrane patching events following physical damage to skeletal myofibers. We documented dysferlin expression in vascular tissues including non-muscle endothelial cells, suggesting that blood vessels may have an endogenous repair system that helps promote vascular homeostasis. To test this hypothesis, we generated dysferlin-null mice lacking apolipoprotein E (ApoE), a common model of atherosclerosis, dyslipidemia and endothelial injury when stressed with a high fat, and cholesterol-rich diet. Despite high dysferlin expression in mouse and human atheromatous plaques, loss of dysferlin did not affect atherosclerotic burden as measured in the aortic root, arch, thoracic, and abdominal aortic regions. Interestingly, we observed that dysferlin-null mice exhibit lower plasma high-density lipoprotein cholesterol (HDL-C) levels than their WT controls at all measured stages of the disease process. Western blotting revealed abundant dysferlin expression in protein extracts from mouse livers, the main regulator of plasma lipoprotein levels. Despite abnormal lipoprotein levels, Dysf\/ApoE double knockout mice responded to cholesterol absorption blockade with lower total cholesterol and blunted atherosclerosis. Our study suggests that dysferlin does not protect against atherosclerosis or participate in cholesterol absorption blockade but regulates basal plasma lipoprotein composition. Dysferlinopathic patients may be dyslipidemic without greater atherosclerotic burden while remaining responsive to cholesterol absorption blockade.<\/jats:p>","DOI":"10.3389\/fphys.2021.675322","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:17:54Z","timestamp":1626959874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions"],"prefix":"10.3389","volume":"12","author":[{"given":"Zoe","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Milad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie L.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.","volume":"303","author":"Altmann","year":"2004","journal-title":"Science (New York, N.Y.)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature01573","article-title":"Defective membrane repair in dysferlin-deficient muscular dystrophy.","volume":"423","author":"Bansal","year":"2003","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/01.atv.0000036081.01231.16","article-title":"Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering.","volume":"22","author":"Bea","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"30745","DOI":"10.1074\/jbc.m704798200","article-title":"Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function.","volume":"282","author":"Bernatchez","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.atv.0000051384.43104.fc","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk.","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030534","article-title":"Functions of vertebrate ferlins.","volume":"9","author":"Bulankina","year":"2020","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.expneurol.2016.06.026","article-title":"Dysferlin function in skeletal muscle: possible pathological mechanisms and therapeutical targets in dysferlinopathies.","author":"Cardenas","year":"2016","journal-title":"Exp. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2353\/ajpath.2009.080930","article-title":"Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.","volume":"175","author":"Chase","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1093\/hmg\/ddp121","article-title":"Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.","volume":"18","author":"Chiu","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nmd.2006.09.006","article-title":"Dysferlin expression in monocytes: a source of mRNA for mutation analysis.","volume":"17","author":"De Luna","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"14147","DOI":"10.1074\/jbc.M112.448589","article-title":"Dysferlin regulates cell adhesion in human monocytes.","volume":"288","author":"de Morr\u00e9e","year":"2013","journal-title":"J. Biolo. Chem."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029061","article-title":"Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.","volume":"6","author":"Gallardo","year":"2011","journal-title":"PloS One"},{"key":"B13","article-title":"Improved genotyping of the dysferlin null mouse.","author":"Han","year":"2011","journal-title":"Protoc. Exch."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000089","article-title":"The Clinical outcome study for dysferlinopathy: an international multicenter study.","volume":"2","author":"Harris","year":"2016","journal-title":"Neurol. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0896-6273(88)90191-2","article-title":"Cell and fiber-type distribution of dystrophin.","volume":"1","author":"Hoffman","year":"1988","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.cir.103.6.864","article-title":"Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin.","volume":"103","author":"Loufrani","year":"2001","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease.","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat. Protoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13395-017-0135-9","article-title":"Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.","volume":"7","author":"Milad","year":"2017","journal-title":"Skelet. Muscle"},{"key":"B19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis.","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.lfs.2005.08.041","article-title":"MDOCTM and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE\u2013\/\u2013 mouse model of atherosclerosis.","volume":"78","author":"Nachtigal","year":"2006","journal-title":"Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2353\/ajpath.2008.070327","article-title":"Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.","volume":"172","author":"Nagaraju","year":"2008","journal-title":"Am. J. Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/qjmed\/hci074","article-title":"Worsening myopathy associated with ezetimibe in a patient with McArdle disease.","volume":"98","author":"Perez-Calvo","year":"2005","journal-title":"QJM"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.2353\/ajpath.2010.090058","article-title":"Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.","volume":"176","author":"Rawat","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease.","volume":"138","author":"Ross","year":"1999","journal-title":"Am. Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1194\/jlr.M079459","article-title":"Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.","volume":"59","author":"Sellers","year":"2018","journal-title":"J. Lipid Res."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/srep13904","article-title":"Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice.","volume":"5","author":"Shami","year":"2015","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1161\/ATVBAHA.110.208108","article-title":"A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis.","volume":"30","author":"Sharma","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mri.2017.01.001","article-title":"Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: in vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.","volume":"38","author":"Srivastava","year":"2017","journal-title":"Magn. Reson. Imaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/nbm.1419","article-title":"High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance.","volume":"23","author":"Srivastava","year":"2010","journal-title":"NMR Biomed."},{"key":"B30","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017.","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neures.2005.01.006","article-title":"Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).","volume":"52","author":"Suzuki","year":"2005","journal-title":"Neurosci. Res."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142430","article-title":"Ezetimibe attenuates atherosclerosis associated with lipid reduction and inflammation inhibition.","volume":"10","author":"Tie","year":"2015","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/ijmm.2020.4798","article-title":"Mechanism overview and target mining of atherosclerosis: endothelial cell injury in atherosclerosis is regulated by glycolysis (Review).","volume":"47","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"459.e","DOI":"10.1016\/j.jacl.2020.05.098","article-title":"High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.","volume":"14","author":"White","year":"2020","journal-title":"J. Clini. Lipidol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/ndt\/17.10.1728","article-title":"Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer.","volume":"17","author":"Woywodt","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1161\/01.atv.19.11.2762","article-title":"Hypertension and endothelial dysfunction in apolipoprotein E knockout mice.","volume":"19","author":"Yang","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.vph.2011.04.001","article-title":"Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo.","volume":"55","author":"Yu","year":"2011","journal-title":"Vascul. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.540098","article-title":"Abnormal Expression of Dysferlin in Blood Monocytes Supports Primary Dysferlinopathy in Patients Confirmed by Genetic Analyses.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.675322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:17:59Z","timestamp":1626959879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.675322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":38,"alternative-id":["10.3389\/fphys.2021.675322"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.675322","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"article-number":"675322"}}